Rationale of a study for patient empowerment and shared decision support for cardiorenal syndrome

Abstract

Early detection and aggressive management of underlying causes and comorbidities are the most important aspects of cardiorenal syndrome. Preventing progression to end stage renal and/or cardiac deficiency may improve quality of life and help save health care costs. CARRE (Personalized patient empowerment and shared decision support for cardiorenal disease and comorbidities, EU-FP7 funded project, no.611140) employs internet aware sensors and sources of medical evidence to compile a variety of personalized alerting, planning and educational services. Within this project, patients are empowered and can make shared informed decisions.